Muhammad Aron Pase. 2024. “Tirzepatide: Dual GIP GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity”. ‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes 1 (2): 96-110. https://doi.org/10.66266/inajemd.v1i2.23.